Read More

HF Foods Names Carlos Rodriguez as CFO

HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants throughout the United States ("HF Foods", "HF Group" or the "Company"), is pleased to announce the appointment of Mr. Carlos A. Rodriguez as Chief Financial Officer, effective on or before August 1, 2022. Mr.

HFFG

Read More

Sanofi, Regeneron Announced Dupixent Phase 3 Trial in Children 1 to 11 Years of Age With Eosinophilic Esophagitis Met Its Primary Endpoint of Histological Disease Remission at 16 Weeks With Both Higher and Lower Dose Weight-tiered Regimens

A Phase 3 trial assessing the investigational use of Dupixent® (dupilumab) in children aged 1 to 11 years with eosinophilic esophagitis (EoE) met its primary endpoint of histological disease remission at 16 weeks with both higher and lower dose weight-tiered regimens. There are no approved treatments for children with EoE under 12 years of age. Naimish Patel, M.D.

REGN